
GC75480
BCR-ABL-IN-7
Also known as N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-(4-fluorophenyl)-1,2-oxazole-3-carboxamide
BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor
ChemicalCAS688050-42-2MW385.41FormulaC19H16FN3O3S
- CAS number
- 688050-42-2
- Molecular weight
- 385.41
- Formula
- C19H16FN3O3S
- Solubility
- DMSO: 2 mg/mL (5·19 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- ROZYTPXUZIIHHA-UHFFFAOYSA-N
- Catalogue number
- GC75480
- Brand
- GLPBIO
Computed properties PubChem CID 15988825 · XLogP 4 · TPSA 126 Ų · H-bond donors 2
- XLogP
- 4
- TPSA
- 126 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES C1CCC2=C(C1)C(=C(S2)NC(=O)C3=NOC(=C3)C4=CC=C(C=C4)F)C(=O)N
Computed descriptors from PubChem (CID 15988825), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il